Marshall Fordyce

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

N/A

0Author DataRank · unranked

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Rare emergence of drug resistance in HIV-1 treatment -naïve patients after 48 weeks of treatment with elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide”.

Rare emergence of drug resistance in HIV-1 treatment -naïve patients after 48 weeks of treatment with elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide

HIV Clinical Trials(2016)10.1080/15284336.2016.1142731

N/A

0.416DataRank · unranked

15 citations

Kathryn M. Kitrinos, Marshall Fordyce, Scott McCallister, Michael D. Miller, Christian Callebaut +1 more

Influence of Age on Outcomes in HIV-Infected Adults Initiating Tenofovir Alafenamide Fumarate (TAF) Versus Tenofovir Disoproxil Fumarate (TDF) With Elvitegravir, Cobicistat, and Emtricitabine (E/C/F/TAF versus E/C/F/TDF)

Open Forum Infectious Diseases(2015)10.1093/ofid/ofv133.787

N/A

0DataRank · unranked

0 citations

Michael Saag, Benoit Trottier, Amanda Clarke, Edwin Dejesus, David Parks +7 more